GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Genomtec SA (WAR:GMT) » Definitions » PS Ratio

Genomtec (WAR:GMT) PS Ratio : (As of May. 15, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Genomtec PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Genomtec's share price is zł12.94. Genomtec's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was zł0.00. Hence, Genomtec's PS Ratio for today is .

The historical rank and industry rank for Genomtec's PS Ratio or its related term are showing as below:

WAR:GMT' s PS Ratio Range Over the Past 10 Years
Min: 31.14   Med: 510   Max: 19690
Current: 12940

During the past 6 years, Genomtec's highest PS Ratio was 19690.00. The lowest was 31.14. And the median was 510.00.

WAR:GMT's PS Ratio is ranked worse than
100% of 808 companies
in the Medical Devices & Instruments industry
Industry Median: 3.275 vs WAR:GMT: 12940.00

Genomtec's Revenue per Sharefor the three months ended in Dec. 2023 was zł0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was zł0.00.

During the past 12 months, the average Revenue per Share Growth Rate of Genomtec was -100.00% per year.

During the past 6 years, Genomtec's highest 3-Year average Revenue per Share Growth Rate was 200.00% per year. The lowest was -40.50% per year. And the median was 79.75% per year.

Back to Basics: PS Ratio


Genomtec PS Ratio Historical Data

The historical data trend for Genomtec's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genomtec PS Ratio Chart

Genomtec Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PS Ratio
Get a 7-Day Free Trial - - 346.30 2,905.00 -

Genomtec Quarterly Data
Dec18 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,905.00 772.86 2,140.00 3,966.67 -

Competitive Comparison of Genomtec's PS Ratio

For the Medical Devices subindustry, Genomtec's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genomtec's PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Genomtec's PS Ratio distribution charts can be found below:

* The bar in red indicates where Genomtec's PS Ratio falls into.



Genomtec PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Genomtec's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=12.94/0.001
=

Genomtec's Share Price of today is zł12.94.
Genomtec's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was zł0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Genomtec  (WAR:GMT) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Genomtec PS Ratio Related Terms

Thank you for viewing the detailed overview of Genomtec's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Genomtec (WAR:GMT) Business Description

Traded in Other Exchanges
Address
ul. Stab?owicka 147, PORT Building 2, Wroclaw, POL, 54-066
Genomtec SA is an innovative technology company which works in the area of ?? molecular diagnostics. It is a manufacturer of mobile molecular analyzers. The device are designed to identify pathogens including viruses, bacteria, and fungi by amplifying and detecting specific DNA and RNA fragments.

Genomtec (WAR:GMT) Headlines

No Headlines